Dr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer
Advertisement
Articles by Dr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Elfetabart Drozuntecan Elicits 70% ORR Across Lines of Therapy in SCLC
2
SERENA-4 Misses Primary PFS End Point With Camizestrant Plus Palbociclib in First-Line ER+ Advanced Breast Cancer
3
Extended-Interval Tarlatamab Yields Comparable Exposure, Survival to Q2W Dose in Previously Treated SCLC
4
Dr Grant's Advice for Early-Career Oncologists at WCLC 2026
5